EPO Patents = 3

Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Heeyong Lee (3 out of 3 patents)

Eunyoung Seol (3 out of 3 patents)

Kwonhyeok Yoon (2 out of 2 patents)

4. Yongha Na (2 out of 2 patents)

5. Juhan Lee (1 out of 2 patents)

3 patents: Sort by Forward Citations

1. 12274787 - Sustained-release injection comprising deslorelin, and preparation method therefor (2025-04-14),

2. 11590258 - Vitamin C-containing polycaprolactone microsphere filler and preparation method therefor (2023-02-28),

3. 11311854 - Method for preparing biodegradable microspheres having improved stability and storage stability (2022-04-26),

G2gbio, Inc. is a biotechnology company focused on developing innovative solutions for genomic research and personalized medicine. They specialize in high-throughput genomic sequencing and bioinformatics services that enable researchers to unlock the potential of genomic data. G2gbio aims to facilitate advancements in genomics by providing state-of-the-art technologies and expertise to academic, clinical, and industrial partners. Their mission is to empower scientists in their pursuit of discoveries that can lead to breakthroughs in disease treatment and health management.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

3 Patents

#142 in Daejeon

#2,652 in South Korea

Daejeon, South Korea

G2gbio, Inc.